In vivo experiments have also confirmed that the mechanism of the antitumor effect of YFJP involves alleviating CD8+ T cell exhaustion and improving the immunosuppressive HCC microenvironment.14 The gene discussed is CD8A; the disease is hepatocellular carcinoma.